These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11416738)

  • 1. FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma.
    Zettinig G; Leitha T; Niederle B; Kaserer K; Becherer A; Kletter K; Dudczak R
    Clin Nucl Med; 2001 Jul; 26(7):599-601. PubMed ID: 11416738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
    Wu HS; Huang WS; Liu YC; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(5b):4235-8. PubMed ID: 14666632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer.
    Grünwald F; Menzel C; Bender H; Palmedo H; Willkomm P; Ruhlmann J; Franckson T; Biersack HJ
    Thyroid; 1997 Jun; 7(3):327-35. PubMed ID: 9226199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of
    Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D
    Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
    Frilling A; Tecklenborg K; Görges R; Weber F; Clausen M; Broelsch EC
    Ann Surg; 2001 Dec; 234(6):804-11. PubMed ID: 11729387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.
    Chen YK; Liu FY; Yen RF; Kao CH
    Acad Radiol; 2003 Aug; 10(8):835-9. PubMed ID: 12945916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of thyroid-stimulating hormone on 18F-fluorodeoxyglucose and 99mTc-methoxyisobutylisonitrile uptake in human poorly differentiated thyroid cancer cells in vitro.
    Kim CH; Yoo IeR; Chung YA; Park YH; Kim SH; Sohn HS; Chung SK
    Ann Nucl Med; 2009 Feb; 23(2):131-6. PubMed ID: 19225935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.
    Muros MA; Llamas-Elvira JM; Ramírez-Navarro A; Gómez MJ; Rodríguez-Fernández A; Muros T; López de la Torre M; Becerra A; Carreras JL
    Am J Surg; 2000 Jun; 179(6):457-61. PubMed ID: 11004330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
    Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents.
    Kiratli PO; Kara PP; Ergün EL; Gedikoğlu G
    Ann Nucl Med; 2004 Jul; 18(5):443-6. PubMed ID: 15462407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinoma.
    Fridrich L; Messa C; Landoni C; Lucignani G; Moncayo R; Kendler D; Riccabona G; Fazio F
    Nucl Med Commun; 1997 Jan; 18(1):3-9. PubMed ID: 9061694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
    Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 FDG PET in insular thyroid cancer.
    Diehl M; Graichen S; Menzel C; Lindhorst E; Grünwald F
    Clin Nucl Med; 2003 Sep; 28(9):728-31. PubMed ID: 12972993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Value of
    Okudan B; Seven B; Gülaldı NCM; Çapraz M; Açıkgöz Y
    Curr Med Imaging; 2022; 18(4):404-408. PubMed ID: 34749623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
    Higashi K; Ueda Y; Matsunari I; Kodama Y; Ikeda R; Miura K; Taki S; Higuchi T; Tonami H; Yamamoto I
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):13-21. PubMed ID: 14574513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma.
    Sriprapaporn J; Toopmongkol C; Satayaban B; Chantamoon N
    Ann Acad Med Singap; 2002 Mar; 31(2):195-8. PubMed ID: 11957557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.